<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483427</url>
  </required_header>
  <id_info>
    <org_study_id>1984</org_study_id>
    <nct_id>NCT04483427</nct_id>
  </id_info>
  <brief_title>Multimodal Postoperative Analgesia Following OSA Surgery</brief_title>
  <official_title>Multimodal Postoperative Analgesia Using Accufuser for Multilevel Surgery for Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bahaa Mohammed Refaie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen&#xD;
      consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device&#xD;
      (Accufuser) for postoperative analgesia following multilevel OSA surgeries&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out at zero time (time to shift to PACU) .</time_frame>
    <description>visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 6 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 12 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 18 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 24 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 30 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 36 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 42 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Assessment will be carried out 48 hours postoperatively</time_frame>
    <description>Visual analog pain score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>Zero time ( time to shift to PACU)</time_frame>
    <description>Ramsey sedation scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>Ramsey sedation scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>18 hours postoperatively</time_frame>
    <description>Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>30 hours postoperatively</time_frame>
    <description>Ramsey Sedation scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>36 hours postoperatively</time_frame>
    <description>Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>42 hours postoperatively</time_frame>
    <description>Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation level</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>Ramsey Sedation Ramsey Sedation Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>Zero time ( time to shift to PACU)</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>18 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>30 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>36 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>42 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse effects</measure>
    <time_frame>48 hours postoperatively</time_frame>
    <description>hypoxia, nausea, vomiting, itching</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>OSA patients after multilevel surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Nalbuphine, ketorolac, accufuser</intervention_name>
    <description>multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser)</description>
    <arm_group_label>OSA patients after multilevel surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  physical status of American Society of Anesthesiologists (ASA) II&#xD;
&#xD;
          -  age between 30 - 50 years&#xD;
&#xD;
          -  OSA patients diagnosed by polysomnography and stop-bang questionnaire&#xD;
&#xD;
          -  enrolled for multilevel OSA surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of allergy to the study drugs&#xD;
&#xD;
          -  history of hepatic, cardiopulmonary or renal disease&#xD;
&#xD;
          -  history of any chronic pain on medication&#xD;
&#xD;
          -  history of substance abuse&#xD;
&#xD;
          -  psychiatric disorder&#xD;
&#xD;
          -  lack of patient cooperation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bahaa M Refaie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of anesthesia and ICU sohag university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammed E Ahmed, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lecturer of ENT sohag university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A M Elhalwagy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Consultant of pain medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bahaa M Refaie, MD</last_name>
    <phone>0201026887257</phone>
    <email>bahaarefaay@med.sohag.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sohag faculty of medicine</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bahaa M Refaie, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 16, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Bahaa Mohammed Refaie</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

